Featured News

New data shows how reactions to gluten vary among people with celiac disease. 

The Celiac Disease Foundation recently published an article in Mediaplanet’s Autoimmune Diseases digital campaign.

The Celiac Disease Foundation is proud to have been involved by recruiting patients essential for this trial’s success.

The NIH Accelerating Progress in Celiac Disease Workshop is a direct outcome of our advocacy efforts in Washington, DC. CEO Marilyn Geller was invited to speak about what our celiac community needs. Watch her presentation here.

Anokion SA announced that they have initiated patient dosing in the multiple ascending dose (MAD) portion of its ACeD study.

Fody Food Co. announces its continued support of the Celiac Disease Foundation and the celiac community with its wide range of certified gluten-free and Low Fodmap products.

The ACeD Study is looking for volunteers with celiac disease to participate in a phase 1 clinical trial testing the investigational drug KAN-101.

We are pleased to share that CEO Marilyn Geller will be presenting as the Patient Advocate at the March 18-19 National Institute of Allergy and Infectious Diseases Accelerating Progress in Celiac Disease Workshop. We encourage you to register to attend this seminal virtual meeting.

Rep. Betty McCollum (D-MN) and Rep. Steve Stivers (D-OH) announced the formation of the Congressional Celiac Disease Caucus at the 2021 Celiac Disease Foundation Patient Education & Advocacy Summit.

Hear from the Foundation’s CEO, Marilyn G. Geller, on today’s episode of the Celiac Project Podcast! Learn all about our groundbreaking Patient Education and Advocacy Summit, the monumental ways CDF is helping to advance legislation and research for celiac disease.